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Type 1 diabetes has a substantial genetic component,
with consistent evidence for a susceptibility locus in the
HLA-DR/DQ region (chromosome 6p) and the insulin
gene region (chromosome 11p). Genome scans have
identified >18 other genomic regions that may harbor
putative type 1 diabetes genes. However, evidence for
most regions varies in different data sets. Given the
genetic heterogeneity of type 1 diabetes, studies in
homogeneous genetically isolated populations may be
more successful in mapping susceptibility loci than in
complex outbred populations. We describe a genome-
wide search in a recently Dutch isolated population. We
identified 43 patients that could be traced back to a
common ancestor within 15 generations and performed
a genome-wide scan using a combined linkage- and
association-based approach. In addition to the HLA
locus, evidence for type 1 diabetes loci was observed on
chromosome 8q24 (marker D8S1128) and on chromo-
some 17q24 (marker D17S2059). Both the 8q and 17q
localization are supported by allele-sharing at adjacent
markers in affected individuals. Statistical evidence for
a conserved ancestral haplotype was found for chromo-
some 8q24. Diabetes 51:856–859, 2002
Type 1 diabetes is characterized by an absoluteinsulin deficiency caused by autoimmune de-struction of insulin-producing -cells in the pan-creas. Both genetic and environmental factors
appear to be involved (1). Several haplotypes at the HLA
class II region on chromosome 6p21 are associated with an
increased risk to develop type 1 diabetes (2). Also, 90%
of type 1 diabetes patients of European ancestry have at
least one copy of the HLA-DR3 or DR4 allele, as compared
with 45% in the general population. Almost 40% of type 1
diabetic patients have both alleles, although 3% is ex-
pected based on the frequency of the general population
(3,4). Numerous studies have found several other geno-
types within the HLA region to be associated with type 1
diabetes (referred to as IDDM1). In addition, the insulin
gene on chromosome 11p15 (IDDM2) has been implicated
in the pathogenesis of type 1 diabetes (5).
The HLA class II region and insulin region, identified
using association analysis of candidate genes, account for
50% of the total familial clustering of type 1 diabetes (6).
Several genome-wide linkage studies have identified 18
other genomic regions that may harbor susceptibility loci
for type 1 diabetes; however, many findings could not be
reproduced in other studies (7,8). Although this may
suggest that some of the initial linkage findings have been
false-positive results, it may also reflect genetic heteroge-
neity of type 1 diabetes in diverse ethnic groups.
Mapping disease genes in a genetically isolated popula-
tion rather than a general population of case subjects or
families received considerable attention (9,10). A benefit
of this strategy is that complex traits are expected to be
more homogeneous in isolated populations because of the
small number of founders and genetic drift, increasing the
power of linkage analysis. In the isolated population,
chances are higher that patients have inherited a disease
gene from a common ancestor. Since adjacent markers on
a chromosome are often transmitted together, patients
from recently (since 5–15 generations) isolated popula-
tions with a common ancestor are likely to share consid-
erable stretches of DNA around disease gene(s) (11). Until
now, the focus has been on populations of prolonged
isolation, such as the Finnish and Icelandic populations
(12,13).
We ascertained 46 patients with type 1 diabetes in an
isolated village in the southwestern region of the Nether-
lands. Genealogical information was collected for all 46
patients and revealed that 43 patients (93%) could be
traced back to a common ancestor within 15 generations.
In Fig. 1, the genealogical lineages of these patients are
shown, based on the shortest number of meioses separat-
ing them from a common ancestor. This figure represents
a simplified example of the genealogical structure of this
population. In reality, most patients are related with each
other in several ways via multiple common ancestors. To
ensure a homogeneous study sample, the analyses in this
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study are restricted to these 43 patients who are related
within 15 generations.
Characteristics of the patients are given in Table 1. Only
33 patients (73.3%) carried the HLA-DR3 or DR4 allele, and
only 8 (17.8%) were heterozygous for the DR3/DR4 allele.
These frequencies were lower than expected frequencies
of 90% (P 0.00006) and 40% (P 0.017), which are found
in most Caucasian populations (3,5), suggesting that other
type 1 diabetes genes play a more important role in this
population. The lower frequency of the high-risk HLA
alleles makes this population very suitable for mapping of
new type 1 diabetes genes.
We performed a genome scan using the 43 patients and
86 first-degree relatives. We found evidence for combined
linkage and association with three markers: marker
D6S1014 in the HLA-region on chromosome 6p (P  0.009,
  0.46), marker D8S1128 on chromosome 8q24 (P 
0.003,   0.45), and marker D17S2059 on chromosome
17q24 (P  0.012,   0.65). To confirm that the non-HLA
regions represent true-positive findings, three additional
analyses were performed. First, the risk for type 1 diabetes
was determined for the associated alleles of markers
D8S1128 and D17S2059 as well as for flanking markers in
these regions. We hypothesized that if the initial findings
represent true positive findings, flanking markers in these
regions should also be associated with increased risk for
diabetes. Although the flanking markers in the 8q region
did not show a P value 0.016 in the initial genome scan,
the ancestral alleles of markers D8S592, D8S1179,
D8S1128, and D8S1100 were all associated with an in-
creased risk for type 1 diabetes (Table 2). Also, in the 17q
region, allele-sharing at additional markers by affected
individuals was observed. The ancestral alleles of the
adjacent markers D17S809, D17S1290, D17S2059, and
D17S1301 were all associated with a highly increased risk
for type 1 diabetes (Table 3). Second, after this observa-
tion, a trend analysis was performed for each of these
markers. We hypothesized that if the 8q24 and 17q24
localizations represent true susceptibility loci, the risk for
diabetes should increase with the number of ancestral
alleles present for each marker. For chromosome 8, the
odds ratio (OR) for trend reached a maximum of 6.4 at
D8S1128 (P  0.0005), whereas the lowest OR was ob-
served for marker D8S592 (OR 1.4, P  0.16) and D8S1100
(OR 1.7, P  0.08), located at 18 cM on either side of
D8S1128 (Table 2). This suggests that a susceptibility gene
is probably located around D8S1128. For chromosome 17,
a significant trend was observed for all four markers, in
particular for D17S2059 (OR 3.1, P  0.0005) (Table 3).
Finally, we investigated whether affected individuals
showed evidence for an ancestral haplotype surrounding
the markers identified in the initial screen. Haplotypes
within the 8q region were associated with a highly in-
creased risk for type 1 diabetes, supporting the presence
of a true susceptibility locus inherited from a common
ancestor (Table 4). In the 17q region, the distribution of
two-marker haplotypes was not significantly different be-
tween case and control subjects (data not shown).
To study a possible interaction between the 8q or 17q
FIG. 1. Genealogical lineages of 43 type 1 diabetic patients that could
be traced back to a common ancestor within 15 generations. The figure
is based on the shortest number of meioses separating each person
from this common ancestor.
TABLE 1
Characteristics of 46 type 1 diabetic patients
Male sex 44
Mean age at time of diagnosis (years) 15 (1–30)
Presence of detectable GAD antibodies 39
Presence of detectable IA2 antibodies 24
Presence of both antibodies 15
Frequency of high-risk HLA genotypes
HLA-DR3 and/or HLA-DR4 allele 73.3
Heterozygous HLA-DR3/DR4 17.8
Data are % or means (range).
TABLE 2
Case-control analysis of flanking markers on chromosome 8q
Marker and
genotype
Frequency
in control
subjects
(%)
Frequency
in case
subjects
(%)
Risk
(95% CI) P
D8S592 (125 cM,
allele 150
bp)
0 69.7 48.6 1
1 15.2 40.0 3.8 (1.1–12.6) 0.03
2 15.2 11.4 1.1 (0.3–4.7) 0.91
Trend 1.4 (0.7–2.8) 0.16
D8S1179 (136 cM,
allele 181
bp)
0 46.9 20.6 1
1 50.0 58.8 2.7 (0.9–8.1) 0.08
2 3.1 20.6 14.9 (1.5–146.2) 0.02
Trend 3.3 (1.4–146.2) 0.008
D8S1128 (142 cM,
allele 243
bp)
0 84.4 43.8 1
1 15.6 46.9 5.8 (1.7–19.2) 0.004
2 0 9.4 —
Trend 6.4 (2.0–19.7) 0.0005*
D8S1100 (160 cM,
allele 192
bp)
0 43.8 29.4 1
1 43.8 47.1 1.6 (0.5–4.7) 0.40
2 12.5 23.5 2.8 (0.7–11.9) 0.16
Trend 1.7 (0.8–3.3) 0.08
Results of the case-control analysis for markers on chromosome 8q.
Results are based on the ancestral allele as identified in the initial
screen. *P value calculated by Fisher’s exact test.
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region and the high-risk HLA alleles, a stratified analysis
was performed. In this analysis, the distribution of ances-
tral alleles, as identified in the initial genome scan, was
assessed in individuals with or without the HLA-DR3 or
DR4 allele. The ancestral alleles of marker D8S1179 (P 
0.05) and D8S1128 (P  0.0005) were more frequently
observed in patients with the high-risk HLA-DR4 allele
than in patients without the HLA-DR4 allele, suggesting an
interaction between the susceptibility gene on chromo-
some 8q24 and the HLA-DR locus. No difference in distri-
bution of the ancestral alleles in the 17q region was
observed between the different HLA-subgroups (data not
shown).
Both the 8q24 and 17q24 localization are supported by
statistical trend analysis and by allele-sharing at additional
markers in affected individuals. Very weak evidence of
linkage of chromosome 8 to type 1 diabetes, 5–25 cM
centromeric to our location, has been reported previously
(8,14). Although linkage to this region could not be repli-
cated in a follow-up analysis by Cucca et al. (15), our study
in a homogeneous population supports the initial findings.
No evidence for linkage to chromosome 17 has been
reported before. Therefore, this locus still remains to be
confirmed.
Although it has recently been argued that old genetic
isolates will not prove to be more valuable than outbred
populations for linkage-disequilibrium mapping of com-
mon variants underlying complex disease (16,17), our
study in a recently isolated population has yielded prom-
ising findings.
RESEARCH DESIGN AND METHODS
Patients with type 1 diabetes were ascertained from a genetically isolated
village in the southwest region of the Netherlands. This village was founded by
150 people in the middle of the 18th century, and up until the last decades,
descendants of these founders have lived in social isolation, with minimal
immigration (5%). From the year 1848 on, the population has expanded from
700 up to 20,000 inhabitants. With help from the local health care centers, we
were able to recruit 60 individuals diagnosed with type 1 diabetes via local
physicians. Medical records covering the last 20 years were available for all
patients. The overall participation rate was 77% (n  46). All 46 participants
completed a questionnaire on family and medical history and gave blood
samples for DNA extraction and detection of autoantibodies. Plasma samples
were stored at 70°C within 12 h after venepuncture. GAD and IA2 antibodies
were tested by immunoprecipitation as previously described (18). We applied
the American Diabetes Association criteria for the diagnosis of diabetes to
confirm the diagnosis. A diagnosis of type 1 diabetes was made if diabetes was
diagnosed before the age of 30 years and patients were insulin-dependent
within 1 year after diagnosis. For each patient, at least two first-degree
relatives were asked to give a blood sample to be able to reconstruct
haplotypes.
Collection of genealogical information. To determine which of the sub-
jects were descended primarily from the original founders of the isolated
village, a genealogical search was completed for each patient, using church
and municipal records of births, marriages, and deaths. Genealogical lineages
for each patient were traced back 15 generations.
Genotyping. DNA samples were obtained from peripheral white blood cells.
The genome screen was performed using 391 markers covering the whole
TABLE 3
Case-control analysis of flanking markers on chromosome 17q
Marker and
genotype
Frequency
in control
subjects
(%)
Frequency
in case
subjects
(%)
Risk
(95% CI) P
D17S809 (85 cM,
allele 242 bp)
0 75.0 54.5 1
1 21.9 30.3 1.9 (0.6–6.0) 0.27
2 3.1 15.2 6.7 (0.7–62.1) 0.09
Trend 2.2 (1.0–5.1) 0.03
D17S1290 (91, allele
172 bp)
0 100 83.3 1
1 0 13.9 —
2 0 2.8 —
Trend — 0.01*
D17S2059 (106 cM,
allele 253 bp)
0 48.6 13.2 1
1 37.1 52.6 5.2 (1.5–17.7) 0.008
2 14.3 34.2 8.8 (2.1–37.1) 0.003
Trend 3.1 (1.5–6.3) 0.0005
D17S1301 (116 cM,
allele 154 bp)
0 64.5 30.3 1
1 25.8 51.5 4.3 (1.4–13.2) 0.01
2 9.7 18.2 4.0 (0.8–19.4) 0.09
Trend 2.5 (1.2–5.4) 0.01
Results of the case-control analysis for markers on chromosome 17q.
Results are based on the ancestral allele as identified in the initial
screen. *P value calculated by Fisher’s exact test. The risk for marker
D17S1290 could not be calculated because the ancestral allele was
not present in control subjects.
TABLE 4
Haplotype analysis chromosome 8q
Marker cM Allele (bp) Haplotype
Frequency in control
subjects (%)
Frequency in
case subjects (%) Risk (95% CI) P
D8S592 125 150
Heterozygous 4.8 15.3 3.5 (0.9–13.4) 0.06
Homozygous 0 0 —
Trend —
D8S1179 136 181
Heterozygous 1.6 12.1 9.0 (1.1–74.0) 0.04
Homozygous 0 3.0 —
Trend 9.5 (1.2–73.4) 0.004*
D8S1128 142 243
Heterozygous 3.2 10.6 3.7 (0.7–18.4) 0.07
Homozygous 0 1.5 —
Trend 4.0 (1.0–18.5) 0.05*
D8S1100 160 192
Results of the case-control analysis for haplotypes on chromosome 8q. Haplotypes are based on the ancestral alleles as identified in the initial
screen. *P value calculated by Fisher’s exact test.
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genome, with an average spacing of 10 cM and an average heterozygosity of
0.75 (version 6 of the Weber lab screening set, see http://research.marshfield
clinic.org/genetics/sets/combo.html). PCR products were pooled and loaded
on an ABI377 automated sequencer, and data were analyzed using ABI
GeneScan3.1 and ABI Genotyper2.1 software.
The HLA-DR3 and -DR4 alleles were determined in all participants. DR3
amplification was performed with forward primer (5-TTGTCCACCCGGC
CCCGCT-3; DR3, Gibco BRL), and reverse primer (5-CACGTTTCTTG
GAGTACTCTACGTCTGTGT-3; DR3, Gibco BRL). DR4 amplification was
performed with forward primer (5-GTTTCTTGGAGCAGGTTAAAC-3;
DR4, Gibco BRL), and reverse primer (5-TTCTCGCCGCTGCACTGTGAA-
3; DR4, Gibco BRL).
Statistical analysis. A whole genome scan was performed to test for
combined linkage and association of single markers with type 1 diabetes (19).
The method used is based on a modification of Terwilliger (20) and assumes
that one a priori unknown ancestral allele will be over-represented on
chromosomes that carry the disease mutation. The proportion of disease
chromosomes with this ancestral allele is represented by the parameter . The
procedure was originally applied to unrelated individuals, but it can also be
extended to deal with pedigree data (19). To this end, we modified the ILINK
option of the LINKAGE package, version 5.04. While maximizing the log
likelihood over , the recombination fraction was fixed at 0.01, and the disease
gene frequency was kept constant at 1%, with a penetrance of 40%. Markers
with a P value 0.016 were selected for further analysis.
To confirm the initial findings, the risk for type 1 diabetes was estimated for
subjects carrying the ancestral allele, using the untransmitted alleles and
spouses as control subjects and the type 1 diabetic patients as case subjects.
We hypothesized that flanking markers of the initially significant marker
should also be associated with an increased risk for diabetes. ORs are
presented with 95% CIs as well as P values for trend. Next, ancestral haplotype
were formed, and their association with type 1 diabetes was tested.
Finally, to study a possible interaction between the newly associated
markers and the high-risk HLA alleles, a stratified analysis was performed. In
this analysis, the risk for type 1 diabetes was assessed in individuals with or
without the HLA-DR3 or -DR4 allele.
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